The favourable alliance between CardioMEMS and levosimendan in patients with advanced heart failure.

ABSTRACT:

Aims

We report the results of a real-world study based on heart failure (HF) patients' continuous remote monitoring strategy using the CardioMEMS system to assess the impact of this device on healthcare outcomes, costs, and patients' management and quality of life.

Methods and results

We enrolled seven patients (69.00 ± 4.88 years; 71.43% men) with HF, implanted with CardioMEMS, and daily remote monitored to optimize both tailored adjustments of home therapy and/or hospital infusions of levosimendan. We recorded clinical, pharmacological, biochemical, and echocardiographic parameters and data on hospitalizations, emergency room access, visits, and costs. Following the implantation of CardioMEMS, we observed a 50% reduction in the total number of hospitalizations and a 68.7%

SUBMITTER: Visco V 

PROVIDER: S-EPMC11424304 | biostudies-literature | 2024 Oct

REPOSITORIES: biostudies-literature